Insider Trading Alert - SFLY, ARNA And ENS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Thursday, July 3, 2014, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $252.00 to $5,900,000.00.

Highlighted Stocks Traded by Insiders:

Shutterfly (SFLY) - FREE Research Report

Boris John, who is SVP, Chief Marketing Officer at Shutterfly, sold 3,052 shares at $49.85 on July 3, 2014. Following this transaction, the SVP, Chief Marketing Officer owned 85,104 shares meaning that the stake was reduced by 3.46% with the 3,052-share transaction.

The shares most recently traded at $49.36, down $0.49, or 0.99% since the insider transaction. Historical insider transactions for Shutterfly go as follows:

  • 4-Week # shares bought: 15,000
  • 4-Week # shares sold: 3,052
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 49,134
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 210,650

The average volume for Shutterfly has been 944,200 shares per day over the past 30 days. Shutterfly has a market cap of $1.9 billion and is part of the services sector and diversified services industry. Shares are down 2.24% year-to-date as of the close of trading on Thursday.

Shutterfly, Inc. is engaged in the manufacture and retail of digital personalized products and services in the United States. Currently, there are 6 analysts who rate Shutterfly a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SFLY - FREE

TheStreet Quant Ratings rates Shutterfly as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full Shutterfly Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Arena Pharmaceuticals (ARNA) - FREE Research Report

Lief Jack, who is Chairman, President and CEO at Arena Pharmaceuticals, sold 223,525 shares at $5.85 on July 3, 2014. Following this transaction, the Chairman, President and CEO owned 361,039 shares meaning that the stake was reduced by 38.24% with the 223,525-share transaction.

The shares most recently traded at $5.47, down $0.38, or 7.03% since the insider transaction. Historical insider transactions for Arena Pharmaceuticals go as follows:

  • 4-Week # shares sold: 223,525
  • 12-Week # shares sold: 223,525
  • 24-Week # shares sold: 223,525

The average volume for Arena Pharmaceuticals has been 4.9 million shares per day over the past 30 days. Arena Pharmaceuticals has a market cap of $1.3 billion and is part of the health care sector and drugs industry. Shares are down 0.17% year-to-date as of the close of trading on Thursday.

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. Currently, there are 3 analysts who rate Arena Pharmaceuticals a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARNA - FREE

TheStreet Quant Ratings rates Arena Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Arena Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EnerSys (ENS) - FREE Research Report

Craig John D, who is Chairman, President & CEO at EnerSys, sold 2,510 shares at $70.00 on July 3, 2014. Following this transaction, the Chairman, President & CEO owned 308,162 shares meaning that the stake was reduced by 0.81% with the 2,510-share transaction.

The shares most recently traded at $68.43, down $1.57, or 2.29% since the insider transaction. Historical insider transactions for EnerSys go as follows:

  • 4-Week # shares sold: 6,573
  • 12-Week # shares sold: 35,233
  • 24-Week # shares sold: 168,401

The average volume for EnerSys has been 331,900 shares per day over the past 30 days. EnerSys has a market cap of $3.3 billion and is part of the industrial goods sector and industrial industry. Shares are down 0.58% year-to-date as of the close of trading on Thursday.

EnerSys manufactures, markets, and distributes industrial batteries in North and South America, Europe, the Middle East, Africa, Asia, Australia, and Oceania. The company operates in three segments: Americas, EMEA, and Asia. The stock currently has a dividend yield of 1%. The company has a P/E ratio of 23.1. Currently, there are 3 analysts who rate EnerSys a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENS - FREE

TheStreet Quant Ratings rates EnerSys as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full EnerSys Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%